Search Results - "Herranz, U Anido"

Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study by Ruiz-Bañobre, J., Molina-Díaz, A., Fernández-Calvo, O., Fernández-Núñez, N., Medina-Colmenero, A., Santomé, L., Lázaro-Quintela, M., Mateos-González, M., García-Cid, N., López-López, R., Vázquez, S., Anido-Herranz, U.

“…Few studies have investigated the safety and efficacy of anti-PD-(L)1 antibodies in metastatic urothelial carcinoma (mUC) in daily clinical practice. Knowledge…”
Get full text

A phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS) by Castellano, D., Duran, I., Rodríguez-Vida, A., Crabb, S.J., van der Heijden, M.S., Font Pous, A., Gravis, G., Anido Herranz, U., Protheroe, A., Ravaud, A., Maillet, D., Mendez-Vidal, M.J., Suarez, C., Lorch, A., Sternberg, C.N., Linch, M., Sarker, S.-J., Notta, J., Mousa, K., Powles, T.B.

Get full text

Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial by Ferreiro-Pantín, M., Anido-Herranz, U., Betancor, Y.Z., Cebey-López, V., León-Mateos, L., García-González, J., García-Acuña, S.M., Fernández-Díaz, N., Tubio, J.M.C., López-López, R., Ruiz-Bañobre, J.

“…In the advanced urothelial carcinoma (aUC) scenario there are no consistent immune checkpoint blockade predictive biomarkers. Recently a novel pan-tumor…”
Get full text

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer by Anido-Herranz, U., Fernández-Núñez, N., Afonso-Afonso, J., Santomé-Couto, L., Medina-Colmenero, A., Fernández-Calvo, O., Lázaro-Quintela, M., Vázquez, S.

“…Administration of chemotherapy in prostate cancer depends on patient fitness. In unfit patients, physiological impairment determines the optimum treatment…”
Get full text

Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer by PADÍN-IRUEGAS, MARIA-ELENA, HERRANZ-CARNERO, MICHEL, AGUIN-LOSADA, SANTIAGO, BROZOS-VAZQUEZ, ELENA, ANIDO-HERRANZ, U, ANTUNEZ-LOPEZ, JOSE-RAMON, RUIBAL-MORELL, ALVARO, LÓPEZ-LÓPEZ, RAFAEL

“…Cancer stem cells play an important role in carcinogenesis and resistance to treatment and may lead to metastasis. The isolation of circulating stem cells…”
Get full text

Approach of the patient with renal cancer: Is there a collaboration between urology and oncology? by Pérez-Salgado, F. Sabell, Vázquez-Estévez, S., Anido-Herranz, U., Blanco-Parra, M., Casas-Nebra, F.J., Fernández-Calvo, O., Lázaro-Quintela, M., López-García, S.

Get full text

High dose neoadjuvant radiochemotherapy in poor-risk rectal cancer by Calvo Crespo, P, Taboada Valladares, B, Peleteiro Higuero, P, Carballo Castro, A, Formoso García, I, Castro Gómez, E, Varela Pazos, A, Anido Herranz, U, García Figueiras, R, Alvarez Castro, A, Luna Vega, V, Paredes Cotoré, J, Gómez Caamaño, A

Get full text

High dose neoadyuvant radiochemotherapy in locally advanced lung cancer by Taboada Valladares, B, Calvo Crespo, P, Peleteiro Higuero, P, Formoso García, I, Varela Pazos, A, Carballo Castro, A, Castro Gómez, E, Anido Herranz, U, Sánchez García, M, Luna Vega, V, Vázquez Vázquez, R, Gómez Caamaño, A

Get full text

Radical radiochemotherapy in locally advanced lung cancer, a monoinstutional experience by Taboada Valladares, B, Calvo Crespo, P, Peleteiro Higuero, P, Formoso García, I, Varela Pazos, A, Carballo Castro, A, Castro Gómez, E, Anido Herranz, U, Sánchez García, M, Luna Vega, V, Vázquez Vázquez, R, Gómez Caamaño, A

Get full text

Adjuvant treatment in locally advanced gastric cancer: A monoinstitutional experience by Formoso García, I, Carballo Castro, A, Calvo Crespo, P, Taboada Valladares, B, Ponte García, C, Peleteiro Higuero, P, Varela Pazos, A, Castro Gómez, J, Anido Herranz, U, Ambroa Rey, E, Álvarez Castro, A, Parada González, P, Lesquereux Martínez, L, Gomez Caamaño, A

Get full text

2373P Outcomes by retrospective eligibility for maintenance therapy of patients (pts) with advanced urothelial carcinoma (UC): Post hoc analysis of KEYNOTE-361 by Mamtani, R., Matsubara, N., Montesa Pino, A., Anido Herranz, U., Sendur, M.A.N., Gravis, G., Huillard, O., Lee, H.J., Gafanov, R., Joly Lobbedez, F., Bedke, J., Sella, A., Chang, Y.H., Imai, K., Homet Moreno, B., Xu, J., Alva, A., Powles, T.B.

Get full text

2393P Ephrin signalling mediates resistance to programmed death ligand 1 (PD-L1) inhibition in urothelial carcinoma (UC) by Yang, Y-H., Cubuk, C., Castellano Gauna, D.E., Banchereau, R., Kockx, M., Rodriguez-Vida, A., Duran Martinez, I., Crabb, S., van der Heijden, M.S., Font Pous, A., Gravis, G., Anido Herranz, U., Protheroe, A., Ravaud, A., Jackson-Spence, F., Toms, C., Mousa, K., Prendergast, A., Szabados, B.E., Powles, T.B.

Get full text

951 POSTER Survival after radiotherapy of metastatic spinal cord compression by Castro-Gomez, E, Anido-Herranz, U, Varela-Pazos, A, Areses-Manrique, C, Fernandez-Fernandez, E, Aguin-Losada, E, Gonzalez-Patiño, E, Gomez-Caamaño, A, Carballo-Castro, A, Porto-Vazquez, C

Get full text

199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis by Szabados, B.E., Rodriguez-Vida, A., Duran, I., Crabb, S.J., van der Heijden, M.S., Pous, A. Font, Gravis, G., Herranz, U. Anido, Protheroe, A., Ravaud, A., Maillet, D., Mendez, M.J., Suarez, C., Linch, M., Prendergast, A., Tyson, C., Mousa, K., Castellano, D., Powles, T.B.

Get full text

Impact of the 8th edition AJCC classification in early stage lung cancer by Cortegoso Mosquera, A.S., Vieito Villar, M., Rodriguez Lopez, C., Varela Pose, V., Cebey Lopez, V., Alvarez Fernandez, J., Perez Martelo, M., Aguin Losada, S., Anido Herranz, U., Leon Mateos, L., Baron Duarte, F.J., Garcia Gonzalez, J.J.

Get full text

1351PImpact of the 8th edition AJCC classification in early stage lung cancer by Cortegoso Mosquera, A S, Vieito Villar, M, Rodriguez Lopez, C, Varela Pose, V, Cebey Lopez, V, Alvarez Fernandez, J, Perez Martelo, M, Aguin Losada, S, Anido Herranz, U, Leon Mateos, L, Baron Duarte, F J, Garcia Gonzalez, J J

Get full text

877PSerum biomarkers of bone metabolism in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): Results from a prospective multicentre study by Laorden, N Romero, Mejorada, R Lozano, Jorge, A Hernández, Lainez, N, Casado, E Almagro, Calvo, O Fernández, Hernando, S, Freire, A Fernández, Billalabeitia, E Gonzalez, Chirivella, I, Domínguez, R García, Herranz, U Anido, Mazon, F J Vazquez, Ros, S, Montesa, A, De Velasco Oria de Rueda, G A, Barrera, R Morales, Lorente, D, Castro, E, Hidalgo, D Olmos

“…Abstract Background Ra223 is a life-prolonging alpha-emitter bone targeted therapy for mCRPC patients with bone metastases. However, evidence on biomarkers…”
Get full text

877P - Serum biomarkers of bone metabolism in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): Results from a prospective multicentre study by Laorden, N Romero, Mejorada, R Lozano, Jorge, A Hernández, Lainez, N., Casado, E Almagro, Calvo, O Fernández, Hernando, S., Freire, A Fernández, Billalabeitia, E Gonzalez, Chirivella, I., Domínguez, R García, Herranz, U Anido, Mazon, F J Vazquez, Ros, S., Montesa, A., De Velasco Oria de Rueda, G.A., Barrera, R Morales, Lorente, D., Castro, E., Hidalgo, D Olmos

“…Ra223 is a life-prolonging alpha-emitter bone targeted therapy for mCRPC patients with bone metastases. However, evidence on biomarkers that may help us in…”
Get full text

Serum biomarkers of bone metabolism in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): Results from a prospective multicentre study by Laorden, N Romero, Mejorada, R Lozano, Jorge, A Hernández, Lainez, N., Casado, E Almagro, Calvo, O Fernández, Hernando, S., Freire, A Fernández, Billalabeitia, E Gonzalez, Chirivella, I., Domínguez, R García, Herranz, U Anido, Mazon, F J Vazquez, Ros, S., Montesa, A., De Velasco Oria de Rueda, G.A., Barrera, R Morales, Lorente, D., Castro, E., Hidalgo, D Olmos

Get full text

899PA phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS) by Castellano, D, Duran, I, Rodríguez-Vida, A, Crabb, S J, van der Heijden, M S, Font Pous, A, Gravis, G, Anido Herranz, U, Protheroe, A, Ravaud, A, Maillet, D, Mendez-Vidal, M J, Suarez, C, Lorch, A, Sternberg, C N, Linch, M, Sarker, S-J, Notta, J, Mousa, K, Powles, T B

Get full text